A citation-based method for searching scientific literature

T M Bryan, A Englezou, L Dalla-Pozza, M A Dunham, R R Reddel. Nat Med 1997
Times Cited: 931



Jeremy D Henson, Ying Cao, Lily I Huschtscha, Andy C Chang, Amy Y M Au, Hilda A Pickett, Roger R Reddel. Nat Biotechnol 2009
Times Cited: 260




List of shared articles



Times cited

Nuclear envelope tethering inhibits the formation of ALT-associated PML bodies in ALT cells.
Chia-Wei Yang, Meng-Hsun Hsieh, Hao-Jhe Sun, Shu-Chun Teng. Aging (Albany NY) 2021
0

Telomeric Double Strand Breaks in G1 Human Cells Facilitate Formation of 5' C-Rich Overhangs and Recruitment of TERRA.
Christopher B Nelson, Taghreed M Alturki, Jared J Luxton, Lynn E Taylor, David G Maranon, Keiko Muraki, John P Murnane, Susan M Bailey. Front Genet 2021
0

ALT Positivity in Human Cancers: Prevalence and Clinical Insights.
Danny MacKenzie, Andrea K Watters, Julie T To, Melody W Young, Jonathan Muratori, Marni H Wilkoff, Rita G Abraham, Maria M Plummer, Dong Zhang. Cancers (Basel) 2021
0

The triggers of the cGAS-STING pathway and the connection with inflammatory and autoimmune diseases.
Ruoyu Zhou, Xiaoli Xie, Xinbo Li, Ziyi Qin, Chuanyu Wei, Jing Liu, Ying Luo. Infect Genet Evol 2020
11

SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness.
Nathaniel J Robinson, Chevaun D Morrison-Smith, Alex J Gooding, Barbara J Schiemann, Mark W Jackson, Derek J Taylor, William P Schiemann. Life Sci Alliance 2020
3


Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells.
Sevil Zencir, Meng-Hsun Hsieh, Joel-Sean Hsu, Yavuz Ergun, Guan-Ling Chou, Tsai-Kun Li, Shu-Chun Teng, Zeki Topcu. J Cancer Res Clin Oncol 2020
2

A critical role of telomere chromatin compaction in ALT tumor cell growth.
Guang Shi, Yang Hu, Xing Zhu, Yuanling Jiang, Junjie Pang, Chuanle Wang, Wenjun Huang, Yong Zhao, Wenbin Ma, Dan Liu,[...]. Nucleic Acids Res 2020
0

A small molecule compound IX inhibits telomere and attenuates oncogenesis of drug-resistant leukemia cells.
Yinghui Li, Jiali Gu, Yahui Ding, Huier Gao, Yafang Li, Yue Sun, Mei He, Wenshan Zhang, Jingjing Yin, Cuigai Bai,[...]. FASEB J 2020
0

Clinical Relevance of Alternative Lengthening of Telomeres in Cancer.
Guilherme G da Silva, Karollyne S Morais, Daniel S Arcanjo, Diêgo M de Oliveira. Curr Top Med Chem 2020
0

ALT: A Multi-Faceted Phenomenon.
Aurore Sommer, Nicola J Royle. Genes (Basel) 2020
3

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies.
Thomas Kent, Deanne Gracias, Samuel Shepherd, David Clynes. Front Oncol 2020
7

Alternative Lengthening of Telomeres: Building Bridges To Connect Chromosome Ends.
Song My Hoang, Roderick J O'Sullivan. Trends Cancer 2020
9

Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres.
Taylor K Loe, Julia Su Zhou Li, Yuxiang Zhang, Benura Azeroglu, Michael Nicholas Boddy, Eros Lazzerini Denchi. Genes Dev 2020
17

Telomere Maintenance Associated Mutations in the Genetic Landscape of Gynecological Mucosal Melanoma.
Guangwen Yuan, Jinge Song, Ning Li, Qianqian Song, Yifei Li, Yingxi Du, Xiaobing Wang, Yuchen Jiao, Lingying Wu. Front Oncol 2020
1


ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition.
Dalal Bakhos-Douaihy, Chantal Desmaze, Maya Jeitany, Laurent R Gauthier, Denis Biard, Marie-Pierre Junier, Hervé Chneiweiss, François D Boussin. Oncotarget 2019
2

TelomereHunter - in silico estimation of telomere content and composition from cancer genomes.
Lars Feuerbach, Lina Sieverling, Katharina I Deeg, Philip Ginsbach, Barbara Hutter, Ivo Buchhalter, Paul A Northcott, Sadaf S Mughal, Priya Chudasama, Hanno Glimm,[...]. BMC Bioinformatics 2019
9

RAD51AP1 Is an Essential Mediator of Alternative Lengthening of Telomeres.
Jonathan Barroso-González, Laura García-Expósito, Song My Hoang, Michelle L Lynskey, Justin L Roncaioli, Arundhati Ghosh, Callen T Wallace, Marco de Vitis, Mauro Modesti, Kara A Bernstein,[...]. Mol Cell 2019
13

SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.
Stephanie Panier, Marija Maric, Graeme Hewitt, Emily Mason-Osann, Himabindu Gali, Anqi Dai, Adam Labadorf, Jean-Hugues Guervilly, Philip Ruis, Sandra Segura-Bayona,[...]. Mol Cell 2019
23

Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Flavia S Donaires, Raquel M Alves-Paiva, Fernanda Gutierrez-Rodrigues, Fernanda Borges da Silva, Maria Florencia Tellechea, Lilian Figueiredo Moreira, Barbara A Santana, Fabiola Traina, Cynthia E Dunbar, Thomas Winkler,[...]. Stem Cell Res 2019
4

Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.
Mindy K Graham, Jiyoung Kim, Joseph Da, Jacqueline A Brosnan-Cashman, Anthony Rizzo, Javier A Baena Del Valle, Lionel Chia, Michael Rubenstein, Christine Davis, Qizhi Zheng,[...]. Mol Cancer Res 2019
8

The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas.
Nathalie Grandin, Bruno Pereira, Camille Cohen, Pauline Billard, Caroline Dehais, Catherine Carpentier, Ahmed Idbaih, Franck Bielle, François Ducray, Dominique Figarella-Branger,[...]. Acta Neuropathol Commun 2019
2

Telomere Maintenance in Pediatric Cancer.
Sandra Ackermann, Matthias Fischer. Int J Mol Sci 2019
1

Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells.
Kathryn E Yost, Sarah F Clatterbuck Soper, Robert L Walker, Marbin A Pineda, Yuelin J Zhu, Corbin D Ester, Soyeon Showman, Anna V Roschke, Joshua J Waterfall, Paul S Meltzer. Sci Rep 2019
14



ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.
Fei Li, Zhong Deng, Ling Zhang, Caizhi Wu, Ying Jin, Inah Hwang, Olga Vladimirova, Libo Xu, Lynnie Yang, Bin Lu,[...]. EMBO J 2019
16